Table of Contents

• Dean T. Eurich,
• Sumit R. Majumdar,
• Finlay A. McAlister,
• Ross T. Tsuyuki,
• and Jeffrey A. Johnson

Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure

• Lawrence S. Phillips,
• David C. Ziemer,
• Joyce P. Doyle,
• Catherine S. Barnes,
• Paul Kolm,
• William T. Branch,
• Jane M. Caudle,
• Curtiss B. Cook,
• Virginia G. Dunbar,
• Imad M. El-Kebbi,
• Daniel L. Gallina,
• Risa P. Hayes,
• Christopher D. Miller,
• Mary K. Rhee,
• Dennis M. Thompson,
• and Clyde Watkins

An Endocrinologist-Supported Intervention Aimed at Providers Improves Diabetes Management in a Primary Care Site: Improving Primary Care of African Americans with Diabetes (IPCAAD) 7

• Bruce W. Bode,
• Sherwyn Schwartz,
• Harrison A. Stubbs,
• and Jon E. Block

Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: Normative values

• N. Wah Cheung,
• Brett Napier,
• Cathy Zaccaria,
• and John P. Fletcher

Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition

• Tamara Hershey,
• Dana C. Perantie,
• Stacie L. Warren,
• Emily C. Zimmerman,
• Michelle Sadler,
• and Neil H. White

Frequency and Timing of Severe Hypoglycemia Affects Spatial Memory in Children With Type 1 Diabetes

• Claudia Perrone,
• Orlando Laitano,
• and Flávia Meyer

Effect of Carbohydrate Ingestion on the Glycemic Response of Type 1 Diabetic Adolescents During Exercise

• Emilia Papakonstantinou,
• Demosthenes B. Panagiotakos,
• Christos Pitsavos,
• Christina Chrysohoou,
• Antonis Zampelas,
• Yannis Skoumas,
• and Christodoulos Stefanadis

Food Group Consumption and Glycemic Control in People With and Without Type 2 Diabetes: The ATTICA study

• Loretta Vileikyte,
• Howard Leventhal,
• Jeffrey S. Gonzalez,
• Mark Peyrot,
• Richard R. Rubin,
• Jan S. Ulbrecht,
• Adam Garrow,
• Christine Waterman,
• Peter R. Cavanagh,
• and Andrew J.M. Boulton

Diabetic Peripheral Neuropathy and Depressive Symptoms: The association revisited

• Gisela Dahlquist and
• Bengt Källén

Mortality in Childhood-Onset Type 1 Diabetes: A population-based study

• Francisco J. Nóvoa,
• Mauro Boronat,
• Pedro Saavedra,
• Juan M. Díaz-Cremades,
• Valois F. Varillas,
• Fátima La Roche,
• María P. Alberiche,
• and Armando Carrillo

Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation: The Telde Study

• Anneli Sepa,
• Ann Frodi,
• and Johnny Ludvigsson

Mothers’ Experiences of Serious Life Events Increase the Risk of Diabetes-Related Autoimmunity in Their Children

• Avan Aihie Sayer,
• Elaine M. Dennison,
• Holly E. Syddall,
• Helen J. Gilbody,
• David I.W. Phillips,
• and Cyrus Cooper

Type 2 Diabetes, Muscle Strength, and Impaired Physical Function: The tip of the iceberg?

• William H. Polonsky,
• Lawrence Fisher,
• Susan Guzman,
• Leonel Villa-Caballero,
• and Steven V. Edelman

Psychological Insulin Resistance in Patients With Type 2 Diabetes: The scope of the problem

• Klaus M. Rave,
• Leszek Nosek,
• Amparo de la Peña,
• Mary Seger,
• Charles S. Ernest II,
• Lutz Heinemann,
• Richard P. Batycky,
• and Douglas B. Muchmore

Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro

• Nicola Scopinaro,
• Giuseppe Maria Marinari,
• Giovanni Bruno Camerini,
• Francesco Saverio Papadia,
• and Gian Franco Adami

Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A long-term follow-up study

• William L. Clarke,
• Stacey Anderson,
• Leon Farhy,
• Marc Breton,
• Linda Gonder-Frederick,
• Daniel Cox,
• and Boris Kovatchev

Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose–Error Grid Analysis

• Paul C. Davidson,
• R. Dennis Steed,
• and Bruce W. Bode

Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation

• Leendert H. Oterdoom,
• Aiko P.J. de Vries,
• Willem J. van Son,
• Jaap J. Homan van der Heide,
• Rutger J. Ploeg,
• Ron T. Gansevoort,
• Paul E. de Jong,
• Rijk O.B. Gans,
• and Stephan J.L. Bakker

Validation of Insulin Resistance Indexes in a Stable Renal Transplant Population

• Shekher Anuradha,
• Venkatesan Radha,
• Raj Deepa,
• Torben Hansen,
• Bendix Carstensen,
• Oluf Pedersen,
• and Viswanathan Mohan

A Prevalent Amino Acid Polymorphism at Codon 98 (Ala98Val) of the Hepatocyte Nuclear Factor-1α Is Associated With Maturity-Onset Diabetes of the Young and Younger Age at Onset of Type 2 Diabetes in Asian Indians

• Caroline S. Fox,
• Martin G. Larson,
• Eric P. Leip,
• James B. Meigs,
• Peter W.F. Wilson,
• and Daniel Levy

Glycemic Status and Development of Kidney Disease: The Framingham Heart Study

• David G. Bruce,
• Wendy A. Davis,
• and Timothy M.E. Davis

Longitudinal Predictors of Reduced Mobility and Physical Disability in Patients With Type 2 Diabetes: The Fremantle Diabetes Study

• Peter Henry Scanlon,
• Chris Foy,
• Raman Malhotra,
• and Stephen J. Aldington

The Influence of Age, Duration of Diabetes, Cataract, and Pupil Size on Image Quality in Digital Photographic Retinal Screening

• Maria G. Kotoula,
• George N. Koukoulis,
• Elias Zintzaras,
• Constantinos H. Karabatsas,
• and Dimitrios Z. Chatzoulis

Metabolic Control of Diabetes Is Associated With an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation

• Maryam Sadat Farvid,
• Mahmoud Jalali,
• Fereydoun Siassi,
• and Mostafa Hosseini

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes

• Naila Ahmed,
• Roya Babaei-Jadidi,
• Scott K. Howell,
• Paul J. Thornalley,
• and Paul J. Beisswenger

Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes

• Rodolfo Cisneros-Tapia,
• Francisco A. Navarrete,
• Ana C. Gallegos,
• Alma E. Robles-Sardin,
• Rosa O. Méndez,
• and Mauro E. Valencia

Insulin Sensitivity and Associated Risk Factors in Mexican Children and Adolescents

• Alessandro Antonelli,
• Clodoveo Ferri,
• Poupak Fallahi,
• Alessandro Pampana,
• Silvia Martina Ferrari,
• Fernando Goglia,
• and Ele Ferrannini

Hepatitis C Virus Infection: Evidence for an association with type 2 diabetes

• Juris J. Meier,
• Silvia Deifuss,
• Andreas Klamann,
• Volker Launhardt,
• Wolff H. Schmiegel,
• and Michael A. Nauck

Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes: The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)

Lipid, Lipoproteins, C-Reactive Protein, and Hemostatic Factors at Baseline in the Diabetes Prevention Program

• Carlos Lorenzo,
• Ken Williams,
• Clicerio Gonzalez-Villalpando,
• and Steven M. Haffner

The Prevalence of the Metabolic Syndrome Did Not Increase in Mexico City Between 1990–1992 and 1997–1999 Despite More Central Obesity

• Tomoyuki Iwasaki,
• Atsushi Nakajima,
• Masato Yoneda,
• Yoshihiko Yamada,
• Koji Mukasa,
• Koji Fujita,
• Nobutaka Fujisawa,
• Koichiro Wada,
• and Yasuo Terauchi

Serum Ferritin Is Associated With Visceral Fat Area and Subcutaneous Fat Area

• Ambady Ramachandran,
• Snehalatha Chamukuttan,
• Sathyamurthy Immaneni,
• Ravi Marimuthu Shanmugam,
• Nalini Vishnu,
• Vijay Viswanathan,
• and Tuomilehto Jaakko

High Incidence of Glucose Intolerance in Asian-Indian Subjects With Acute Coronary Syndrome

• Yasufumi Doi,
• Yutaka Kiyohara,
• Michiaki Kubo,
• Toshiharu Ninomiya,
• Yoshiyuki Wakugawa,
• Koji Yonemoto,
• Masanori Iwase,
• and Mitsuo Iida

Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population: The Hisayama Study

• Capri Gabrielle Foy,
• Ronny A. Bell,
• Deborah F. Farmer,
• David C. Goff, Jr.,
• and Lynne E. Wagenknecht

Smoking and Incidence of Diabetes Among U.S. Adults: Findings from the Insulin Resistance Atherosclerosis Study

• Gregory G. Schwartz,
• Anders G. Olsson,
• Michael Szarek,
• and William J. Sasiela

Relation of Characteristics of Metabolic Syndrome to Short-Term Prognosis and Effects of Intensive Statin Therapy After Acute Coronary Syndrome: An analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial

• Akira Satoh,
• Hisashi Adachi,
• Makoto Tsuruta,
• Yuji Hirai,
• Akiko Hiratsuka,
• Mika Enomoto,
• Kumiko Furuki,
• Asuka Hino,
• Tomohiro Takeuchi,
• and Tsutomu Imaizumi

High Plasma Level of Remnant-Like Particle Cholesterol in the Metabolic Syndrome

• Marc J. Weigensberg,
• Geoff D.C. Ball,
• Gabriel Q. Shaibi,
• Martha L. Cruz,
• and Michael I. Goran

Decreased β-Cell Function in Overweight Latino Children With Impaired Fasting Glucose

• Auke H. Brantsma,
• Stephan J.L. Bakker,
• Hans L. Hillege,
• Dick de Zeeuw,
• Paul E. de Jong,
• and Ronald T. Gansevoort

Urinary Albumin Excretion and Its Relation With C-Reactive Protein and the Metabolic Syndrome in the Prediction of Type 2 Diabetes

• Jonas Lidfeldt,
• Christina Nerbrand,
• Göran Samsioe,
• and Carl-David Agardh

Women Living Alone Have an Increased Risk to Develop Diabetes, Which Is Explained Mainly by Lifestyle Factors

• Weili Yan,
• Xiaoyan Yang,
• Yujian Zheng,
• Dongliang Ge,
• Yuanming Zhang,
• Zimei Shan,
• Ha Simu,
• Musilin Sukerobai,
• and Ren Wang

The Metabolic Syndrome in Uygur and Kazak Populations

• Rita S. Suri,
• William F. Clark,
• Nick Barrowman,
• Jeffrey L. Mahon,
• Heather R. Thiessen-Philbrook,
• M. Patricia Rosas-Arellano,
• Kelly Zarnke,
• Jocelyn S. Garland,
• and Amit X. Garg

Diabetes During Diarrhea-Associated Hemolytic Uremic Syndrome: A systematic review and meta-analysis

• Patricia L. Brubaker

Adventure Travel and Type 1 Diabetes: The complicating effects of high altitude

• Robert I. Misbin

Evaluating the Safety of Diabetes Drugs: Perspective of a Food and Drug Administration insider

• Zachary T. Bloomgarden

2nd International Symposium on Triglycerides and HDL: Metabolic syndrome

• Silvio E. Inzucchi

Metformin and Heart Failure: Innocent until proven guilty

• Nami Nishikiori,
• Yoshinori Mitamura,
• Asako Tashimo,
• Yasushi Nakamura,
• Takayuki Harada,
• Makoto Osanai,
• Norimasa Sawada,
• and Kenji Ohtsuka

Glial Cell Line–Derived Neurotrophic Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy

• Fernando Guerrero-Romero and
• Martha Rodr&ıacute;guez-Morán

Concordance Between the 2005 International Diabetes Federation Definition for Diagnosing Metabolic Syndrome With the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization Definitions

• Janaka Karalliedde,
• Andy Smith,
• and Giancarlo Viberti

Determinants of Response to Insulin Therapy Following Failure of Oral Agents in Type 2 Diabetes

• Hiroyuki Shimizu,
• Shuichi Okada,
• Oh-I Shinsuke,
• and Masatomo Mori

Kremezin (AST-120) Delays the Progression of Diabetic Nephropathy in Japanese Type 2 Diabetic Patients

• Michio Otsuki,
• Soji Kasayama,
• Hiroshi Saito,
• Mikio Mukai,
• and Masafumi Koga

Sex Differences of Age-Dependent Changes of Insulin Sensitivity in Japanese Nondiabetic Subjects

• Suraj A. Muley,
• Gareth J. Parry,
• and Nacide G. Ercan-Fang

Isolated Bibrachial Plexopathy in a Patient With Type 2 Diabetes

• Yasue Omori and
• Lois Jovanovic

Proposal for the Reconsideration of the Definition of Gestational Diabetes

• Inessa M. Gelfand,
• Erica A. Eugster,
• and Nadine G. Haddad

Infancy-Onset Cystic Fibrosis–Related Diabetes

• Jorien M. Woolderink,
• Aren J. van Loon,
• Fred Storms,
• Loek de Heide,
• and Klaas Hoogenberg

Use of Insulin Glargine During Pregnancy in Seven Type 1 Diabetic Women

• Kingston H. Tseng

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)

• Neil R. Poulter,
• Peter S. Sever,
• Björn Dahlöf,
• and Hans Wedel

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)

• Nanne Kleefstra,
• Sebastiaan T. Houweling,
• Evert van Ballegooie,
• and Henk J.G. Bilo

Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin: Response to Welschen et al

• Mayer B. Davidson

Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin: Response to Welschen et al. and Kleefstra et al

• Laura M.C. Welschen,
• Evelien Bloemendal,
• Giel Nijpels,
• Jacqueline M. Dekker,
• Robert J. Heine,
• Wim A.B. Stalman,
• and Lex M. Bouter

Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin: Response to Kleefstra et al. and Davidson

• Nathan D. Wong and
• Shaista Malik

C-Reactive Protein for Cardiovascular Risk Assessment in the Metabolic Syndrome

Erratum